8-K - enGene Therapeutics Inc. - 5.03 / 7.01 / 9.01
Filed: 2026-04-09 AccNo: 0001193125-26-149597 Size: 1 MB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits